Development and validation of a predictive model for recurrence in postoperative patients with stage ⅠA1-ⅢA non-small cell lung cancer
Our multi-source imaging-genomic-clinical model accurately predicts the risk of recurrence after surgery in stage ⅠA1-ⅢA NSCLC patients and can be used for risk stratification to guide clinical follow-up management and postoperative treatment strategies.
Authors
- Zhoufeng Wang (ORCID: https://orcid.org/0000-0002-7881-1837)
- Weimin Li (ORCID: https://orcid.org/0000-0001-6685-0161)
- Jinghong Xian
- Wang Chen (ORCID: https://orcid.org/0000-0003-4723-5395)
- Renjie Xu (ORCID: https://orcid.org/0000-0002-6951-7273)
- Yi Li (ORCID: https://orcid.org/0000-0002-8018-5513)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1186/s12885-025-15275-6
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00